Tessera

Seamless Therapeutics

The company develops programmable recombinase-based gene editing therapies for patients with severe genetic diseases through its proprietary technology platform.

Beam Therapeutics

The company develops precision genetic medicines using base editing technology to treat patients with serious genetic diseases such as sickle cell disease.

EDITAS Medicine

The company develops CRISPR-based genome editing medicines to treat patients with serious genetic diseases, including blood disorders and inherited eye conditions.

Replay Therapeutics

This biotech company develops genome writing and delivery platforms to provide genetic medicines for patients with rare skin, eye and haematological diseases.

Replace Therapeutics

The company develops genome editing technology to insert and delete small DNA sequences for biotechnology firms and healthcare researchers.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Ensoma

This company develops in vivo genomic medicines and vector delivery platforms to engineer blood and immune cells for patients with genetic diseases and cancer.

Alia Therapeutics

The company develops gene editing medicines for patients with genetic diseases.